Literature DB >> 17882728

Goal attainment scaling: current methodological challenges.

Alan Tennant1.   

Abstract

PURPOSE: To validate the underlying mathematical process of Goal Attainment Scaling (GAS), as an illustration of the problems encountered by patient-generated indexes in the quest of patient-centred outcomes.
METHODS: Data are simulated to represent the type of input to GAS. Rasch analysis is used to linearize the response categories for each variable associated with each goal, thus making it possible to compare the ordinal non-linear outcome of the GAS process with its linear equivalent, under the assumption of strict unidimensionality. Using a minimum clinically important difference (MCID), the level of difference between the two estimates is assessed.
RESULTS: Over 14% of the simulated cases showed a magnitude of difference in change scores between the ordinal and linear-based GAS scores greater than the MCID. These differences were most likely to occur when patients start or finish their GAS scores at the margins of the score range, where non-linearity is greatest. The results show that the GAS process does not support mathematical operations such as multiplication. Apparent clinically meaningful changes scores can be generated solely from the non-linear nature of ordinal scores.
CONCLUSIONS: Using patient-centred approaches to measurements such as GAS presents formidable scientific challenges. Suggestions are made which, in the context of GAS applications, may overcome some of these limitations. This involves the establishment of 'item banks' of goals which can be pre-calibrated onto a unidimensional metric such that linearized versions of the various scores (e.g., difficulty) could be imported into the process.

Entities:  

Mesh:

Year:  2007        PMID: 17882728     DOI: 10.1080/09638280701618828

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  19 in total

Review 1.  A systematic review to investigate the measurement properties of goal attainment scaling, towards use in drug trials.

Authors:  Charlotte M W Gaasterland; Marijke C Jansen-van der Weide; Stephanie S Weinreich; Johanna H van der Lee
Journal:  BMC Med Res Methodol       Date:  2016-08-17       Impact factor: 4.615

2.  [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].

Authors:  K Fheodoroff; D Dressler; H Woldag; P Koßmehl; M Koch; P Maisonobe; G Reichel
Journal:  Nervenarzt       Date:  2019-04       Impact factor: 1.214

Review 3.  Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Authors:  Brian J Hoare; Margaret A Wallen; Christine Imms; Elmer Villanueva; Hyam Barry Rawicki; Leeanne Carey
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 4.  Goal setting and strategies to enhance goal pursuit for adults with acquired disability participating in rehabilitation.

Authors:  William M M Levack; Mark Weatherall; E Jean C Hay-Smith; Sarah G Dean; Kathryn McPherson; Richard J Siegert
Journal:  Cochrane Database Syst Rev       Date:  2015-07-20

5.  Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.

Authors:  Lynne Turner-Stokes; Klemens Fheodoroff; Jorge Jacinto; Pascal Maisonobe
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

6.  Modified constraint-induced movement therapy or bimanual occupational therapy following injection of Botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: a randomised controlled trial methods paper.

Authors:  Brian J Hoare; Christine Imms; Hyam Barry Rawicki; Leeanne Carey
Journal:  BMC Neurol       Date:  2010-07-05       Impact factor: 2.474

7.  Effectiveness of functional hand splinting and the cognitive orientation to occupational performance (CO-OP) approach in children with cerebral palsy and brain injury: two randomised controlled trial protocols.

Authors:  Michelle Jackman; Iona Novak; Natasha Lannin
Journal:  BMC Neurol       Date:  2014-07-15       Impact factor: 2.474

8.  Effect of a multifactorial interdisciplinary intervention on mobility-related disability in frail older people: randomised controlled trial.

Authors:  Nicola Fairhall; Catherine Sherrington; Susan E Kurrle; Stephen R Lord; Keri Lockwood; Ian D Cameron
Journal:  BMC Med       Date:  2012-10-15       Impact factor: 8.775

9.  Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice.

Authors:  Lynne Turner-Stokes; Klemens Fheodoroff; Jorge Jacinto; Pascal Maisonobe; Benjamin Zakine
Journal:  BMJ Open       Date:  2013-03-18       Impact factor: 2.692

10.  Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).

Authors:  Lynne Turner-Stokes; Stephen Ashford; Jorge Jacinto; Pascal Maisonobe; Jovita Balcaitiene; Klemens Fheodoroff
Journal:  BMJ Open       Date:  2016-06-17       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.